{
  "compound": "Dronabinol, nabilone",
  "condition": "APPETITE_CACHEXIA",
  "effect_size": "N/A (guideline)",
  "study_type": "CLINICAL_GUIDELINE",
  "source": "NORML:CACHEXIA_GUIDELINE_001",
  "participants": "Evidence-based guideline",
  "year": 2017,
  "notes": "ESPEN Guidelines on Nutrition in Cancer: Cannabinoid Section",
  "confidence": "medium",
  "abstract": "ESPEN position: Cannabinoids may be considered for refractory anorexia when first-line therapies fail; Grade B recommendation"
}